Over the last five years, Vertex's stock has displayed a trend of positive one-day returns in 58% of cases following earnings ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.15% to $462.13 Friday, on what proved to be an all-around grim trading ...

US stock futures are up on Monday after ending Friday deep in the red, following a disappointing jobs report by Bureau of ...

Third, Vertex still has an exciting pipeline in CF and elsewhere. For instance, the company's late-stage candidate for APOL-1 ...

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its second-quarter 2025 results on Aug. 4, ...

This was the stock's third consecutive day of losses.

Vertex's 2025 Mid-Year Report reveals more than 400 implemented changes to U.S. sales tax rates and rules nationwide, ...

Some Boston public school students are spending their summer vacations learning and working at a global biotech company.

Vertex is finding itself a step closer to launching a potential blockbuster. As a result, now may be a great time to buy the shares -- and benefit from this innovative biotech's growth over time.